Skip to content

John Oyler, Chief Executive Officer at BeOne Medicines, sold ONC on Jul 14, 2026

Data as of Oct 16

▼ SELL$14.1M45,895 shares at $306.21John Oyler Chief Executive OfficerONC BeOne Medicines Ltd.
Watch ONC
Traded
Jul 14, 2026
Disclosed
Jul 14, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

John Oyler, Chief Executive Officer at BeOne Medicines, sold ONC on Jul 14, 2026TRADEDDISCLOSED
ONCSimilar stocks (XLV — its sector index fund), rebased to ONC's price on the disclosure day
ONC since disclosure
+20.4%
after the sale
Similar stocks (XLV) since disclosure
+11.6%
XLV — its sector index fund

Change in closing price from Jul 14, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLJohn Oyler Chief Executive OfficerONC BeOne Medicines Ltd.$2.4Mdisclosed Jul 14 · filed the same day
  2. ▼ SELLJohn Oyler Chief Executive OfficerONC BeOne Medicines Ltd.$12.5Mdisclosed Jul 14 · filed the same day
  3. ▼ SELLJohn Oyler Chief Executive OfficerONC BeOne Medicines Ltd.$1.3Mdisclosed Jul 14 · filed the same day
  4. ▼ SELLJohn Oyler Chief Executive OfficerONC BeOne Medicines Ltd.$2.5Mdisclosed Jul 14 · filed the same day
  5. ▼ SELLJohn Oyler Chief Executive OfficerONC BeOne Medicines Ltd.$11.9Mdisclosed Jul 14 · filed the same day

See every trade on ONC →